A lthough effective results are attained with paroxysmal atrial fibrillation (AF) ablation based on pulmonary vein isolation (PVI), catheter ablation of persistent AF remains a challenging task. Current ablation approaches in persistent AF ablation are markedly diverse, and there is a considerable variation in the reported clinical outcomes. 1 Moreover, the lack of a distinct procedural end point makes comparison between the studies difficult.
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Recently, significant advances have been made with the development of novel technologies, such as computational mapping and panoramic noninvasive mapping to map drivers (rotors and focal discharges) during AF. The advent of these newer technologies and strategies for persistent AF ablation further raise the question as to whether AF termination should be the procedural end point, and whether it confers additional long-term clinical benefit.
In this article, we review the current evidence on AF termination and long-term clinical outcome, procedural AF termination as a predictor of freedom from recurrent atrial arrhythmias, AF termination rates with various ablation strategies, and potential underlying mechanisms conferring clinical benefit and future directions.
AF Termination and Clinical Outcome Search Strategy
The English scientific literature in the PubMed database was searched using the terms catheter ablation, persistent AF, and termination in any region of the PubMed record until October 2014. Studies that described procedural AF termination rates during ablation together with clinical outcomes after ablation for patients with persistent AF or long-standing persistent AF were included. References from the relevant articles were reviewed to identify further related articles. Definition of AF termination included direct conversion to sinus rhythm (SR) and organization to atrial tachycardia (AT) during ablation. ablation with those who did not terminate, the majority of studies (17 of 20) demonstrate significantly improved outcomes in the group with procedural AF termination, as listed in Table 1 . [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] In these studies, both increased single procedural success 3, 5, 8, 10, [13] [14] [15] [16] 19, 21 and overall clinical success with multiple procedures 2, 6, 7, [11] [12] [13] [15] [16] [17] 20, 21 were reported when compared with patients who did not achieve AF termination. In a study by Rostock et al, 22 which evaluated the long-term predictors of single-and multiple-procedure outcomes for 395 patients who had undergone persistent AF ablation, AF termination during the index procedure significantly predicted single-procedure success and also a favorable outcome after the final procedure. In a prospective study of 153 patients, O'neill et al 6 showed that SR was maintained in 95% (124/130 patients; 1 had recurrent AF and 5 had AT) of patients in whom AF was terminated in the index procedure when compared with 52% (12/23 patients; 9 had recurrent AF and 2 had AT) in whom AF could not be terminated (P<0.001). In a recent study by Scherr et al, 21 5-year outcomes of 150 patients who underwent persistent AF ablation using AF termination as a procedural end point were reported. During a median follow-up of 58 months after the last ablation procedure, 65% of patients remained in SR without antiarrhythmic medications. Failure to terminate AF during the first procedure was associated with poorer single-and multiple-procedure success and was the strongest multivariate predictor of arrhythmic recurrence after the last ablation procedure (hazard ratio, 3.83; 95% confidence interval, 2.07-7.14; P<0.001). Figures 1 and 2 illustrate single-and multiple-procedure outcomes of studies comparing patients with AF termination versus non-AF termination. Of the 20 studies, 3 studies did not show a beneficial effect with AF termination. 4, 9, 18 Elayi et al 9 studied 306 patients with long-standing persistent AF who underwent ablation. Six of 306 patients converted directly to SR, 172 patients organized into AT, and 128 remained in AF and were cardioverted. Termination of AF during ablation (conversion to AT or AF) predicted the mode of arrhythmia recurrence (AT or AF) but did not affect longterm SR maintenance. However, notably, of the 178 patients in the AF termination group, only 6 patients converted directly to SR, and among the 172 patients who organized into AT, only 38 patients (22%) were successfully ablated to SR, a significantly lower percentage when compared with other studies, 6, 16, 23 which may have affected the results. In the second study, Zhou et al 18 undertook an individualized stepwise ablation strategy in 200 patients with nonparoxysmal AF. Although there was no significant difference in long-term success between the AF termination (to SR/AT) and non-AF termination group (P=0.1), there was a significant difference in longterm success between patients with SR restoration by ablation and those with SR restoration by cardioversion (64% versus 37%; P<0.001). The importance of achieving SR by ablation versus by cardioversion (for AF and intermediate ATs after AF termination) is highlighted in the study, whereby restoration of SR by ablation (odds ratio, 3.03; 95% confidence interval, 1.70-5.40; P<0.001) and AT termination by ablation (odds ratio, 5.81; 95% confidence interval, 2.17-15.60; P<0.001) were the only significant multivariate predictor for long-term single-procedure success in the entire cohort and in the subgroup of patients with intermediate AT, respectively. 18 In the third study, Estner et al 4 studied 35 patients who underwent PVI and complex fractionated atrial electrogram (CFAE) ablation for persistent AF. AF was terminated in 66% (35% to SR and 65% into AT) and 34% persisted in AF. At the end of follow-up, SR was maintained in 88% of the patients who converted to SR during the index procedure versus 73% in the patients with organization into AT and 66% in patients with ongoing AF, P=0.3. Although no significant difference was found, this study was likely limited by its small numbers. In a fourth study, although no specific outcomes were presented, conversion of AF to SR or AT during ablation was reported not to be predictive of freedom from recurrent AF. 24 However, in the study, the AF termination rate was noted to be low (16% by CFAE ablation) by the authors when compared with previous studies and was potentially attributed to the absence of right atrial ablation or the lack of empirical PV isolation.
Why was there a difference in outcome among these studies? There are several possible explanations. First, the definition of AF termination includes termination into SR or AT, and the success in eliminating intermediate ATs differs widely across studies. 3, 6, 9, 16, 23 The rate of successful termination of intermediate ATs impacts heavily on clinical outcomes because patients with AT who are cardioverted have a higher recurrence rate than patients who terminate into SR by ablation. 15, 18 Several studies have also shown that patients who terminated into an AT are more likely to have AT as the type of arrhythmia recurrence, 6, 14, 25 reinforcing the importance of eliminating intermediate ATs in the process of achieving SR. 15, 25 In a recent randomized trial, patients who underwent ablation of subsequent ATs to SR after AF termination were shown to have less AF recurrence than patients randomized to direct cardioversion. 26 Second, the extent of ablation may be a key factor in determining success in AF termination. Many ablation protocols and studies are limited by time or volume load, which may have decreased the AF termination rates. 3, 15, 22, 27 Third, the ablation approach may play a role. The contributory role of linear ablation in addition to electrogram-based ablation and PVI in the stepwise approach is reported to account for 21% of AF termination and 32% of AF/intermediate AT termination. 3, 6 
Procedural AF Termination as a Predictor of Long-Term Clinical Success
Procedural AF termination is shown to be an independent predictor of successful single-procedural 8, 15, 22, 28 and multiple-procedural outcomes in multiple studies, 3, 6, 13, 14, 22, 28 summarized in Table 2 . 18, 19, 29 Park et al, 14 Heist et al, 13 yoshida et al, 29 and Scherr et al 21 reported that AF termination was a multivariate predictor of reduced arrhythmia recurrences and higher clinical success. lin et al 8 found in a study of CFAE ablation in addition to PVI and linear ablation that the most significant predictor for successful ablation of nonparoxysmal AF was procedural AF termination. 15 found that AF termination into SR was associated with a lower risk of arrhythmia recurrence even after adjustment for age, sex, diabetes mellitus, arterial hypertension, lA diameter, and AF duration (hazard ratio, 0.62; P=0.04).
Factors associated with successful AF termination include a shorter duration of persistent AF, longer baseline AF cycle length, smaller lA diameter, and increased lA appendage function, listed in the Table II in the Data Supplement. 6, 7, 17, 25 
Variation in Current Ablation Approaches to Persistent AF and the Lack of a Distinct Procedural End Point
The challenges in persistent AF ablation have resulted in numerous ablation approaches for this disorder. 1 These different approaches have reported markedly varied clinical results, and the difficulty comparing between approaches is compounded by the lack of a distinct procedural end point. Acute AF termination provides an unambiguous and measurable procedural end point that can be assessed in each study, allowing comparison between studies to improve our understanding and approach in treating the arrhythmia.
A list of studies reporting AF termination rates with clinical outcomes is shown in Table I in the Data Supplement, accompanied by a brief summary of the results. Figure 3 summarizes AF termination rates and single-and multipleprocedural clinical outcomes of these studies in relation to the various ablation approaches.
Several studies have investigated the role of concurrent antiarrhythmic drugs (AADs) during ablation to aid AF termination. 30, 31 Singh et al 30 reported the intraprocedural use of ibutilide to organize atrial activity and facilitate AF termination in a modified stepwise approach to persistent AF ablation. This approach may help identify important areas maintaining AF and minimize the ablation lesion set. 30 An ongoing study will further evaluate the application of this method. 32
Benefits of Procedural AF Termination and Potential Mechanisms Improving Clinical Outcome
How does procedural AF termination confer improved clinical outcomes? There are several potential mechanisms and explanations. Table 1 for details). 15 AF termination defined as termination by ablation directly into sinus rhythm (SR), and non-AF termination defined as termination into atrial tachycardia (AT) or persistent AF followed by cardioversion. For Zhou et al, 18 AF termination defined as termination into SR (directly or via intermediate AT) by ablation vs AT/AF followed by cardioversion (refer Table 1 for details).
First, ablation with the end point of AF termination seeks to progressively target the multiple drivers sustaining persistent AF, until most or all of the sources or drivers are eliminated in the particular patient such that AF is no longer maintained. 33 This is consistent with computer simulations of AF, which demonstrate an inverse relationship between the number of sources participating in AF and AF cycle length, with the AF cycle length prolonging at each stage of ablation before achieving a critical cycle length for AF termination. 34 Figure 4 illustrates the impact of each ablation step on local fibrillatory cycle length as each source of AF is eliminated, until AF is terminated. 34 In a study examining changes in AF cycle length in patients undergoing catheter ablation, progressive AF cycle length prolongation was demonstrated with each ablation step in patients leading to AF termination. 35 Termination of AF was predictive of noninducibility after ablation, which in turn was associated with improved long-term outcomes (87% versus 63% freedom from recurrent AF; P=0.03). 35 Second, the targeting of non-PV foci/sources in the process of achieving termination may eliminate further sources triggering/sustaining persistent AF that may be responsible for recurrences. 8, 27, 33 Several studies have indicated that patients with ongoing AF after completion of a predetermined lA ablation strategy harbor sources at less typical sites such as the right atrium, and in these patients further right atrium ablation resulted in successful AF termination and less recurrence of atrial arrhythmias when compared with those without termination. 3, 10, 36 Third, most patients with procedural AF termination, if they sustain arrhythmia recurrence, represent with AT. 6, 22 These ATs can be ablated with a high success rate (93%) and may be seen as a step toward achieving long-term maintenance of SR. 15, 23, 37 
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Distinct Procedural End Point and Benchmark for Comparative Studies
Termination of the arrhythmia provides a clear-cut, robust, and quantifiable procedural end point that can be used as a benchmark to compare between studies, improving our understanding and approach in treating persistent AF.
Individualized Approach and Patient Stratification
When compared with a standard lesion set, a strategy that aims for procedural termination of the arrhythmia provides an individualized framework to identify AF drivers that are peculiar to the individual patient. Persistence of AF after completion of a predetermined lesion set may indicate the presence of residual AF drivers that have not been identified or incomplete ablation of previous drivers. 3, 10, 36 Furthermore, such a strategy allows stratification of the extent of ablation, where one-size-may-not-fit-all, especially in the setting of persistent AF. Pascale et al 20 demonstrated that a lower PV (fastest activity) to lA cycle length gradient predicted procedural AF termination after PVI or limited adjunctive substrate ablation, and that these patients had significantly better long-term outcomes. In an another study, lin et al 38 showed that procedural AF termination could be used to stratify persistent AF patients who respond well to PVI alone versus limited or extensive substrate modification.
Current Limitations
Although an ablation strategy aiming at AF termination may involve longer procedural times, potentially exposing the patient to adverse events, reports from experienced centers using this approach have reported comparable complication rates with other ablation strategies. 3, 6, 21, 22, 39 In certain cases of resistant AF, termination of the arrhythmia by ablation may not be achievable. Patient characteristics such as duration of long-standing persistent AF >2 years and left atrial size help identify poorer responders ( Table II in the Data Supplement). 7, 21 In such cases, operator judgment with a reasonable time limit may help to curtail excessive ablation. 22 Increased ablation can result in a proarrhythmic effect. Although a higher rate of AT is observed with a strategy targeting AF termination, successful elimination of these intermediate ATs and in patients representing with AT (compared with recurrent persistent AF) is shown to result in significantly better outcomes. 26, 37 
Future Directions
Current conventional ablation strategies that aim for AF termination are limited by the lack of specificity of CFAEs in defining AF drivers and the extent of ablation. 40, 41 Recently, newer mapping technologies have emerged to define rotors and localized sources sustaining AF. 42 narayan et al 43 used computational mapping combined with AF activation from a multielectrode basket catheter to identify rotors and focal sources driving AF. By targeting these localized sources, AF terminated in 56% of patients and AF cycle length prolonged in 31% of patients with paroxysmal and persistent AF. Recent developments in body surface mapping have enabled highresolution noninvasive beat-to-beat mapping of atrial activity during AF. 44 With the advent of these panoramic mapping techniques, re-entrant and focal sources driving persistent AF can be identified with more specificity when compared with CFAE. 44, 45 In a recent study by Haissaguerre et al 46 using noninvasive panoramic mapping, patients with persistent AF displayed drivers clustered in regions. The number of driver regions varied among individuals but increased with the duration of continuous AF. Driver ablation alone terminated 75% and 15% of persistent and long-lasting AF, respectively. 46 The AF cycle length was observed to prolong as the driver regions were sequentially ablated until AF termination was achieved. Importantly, when compared with a matched cohort treated by the stepwise ablation approach, clinical success at 12 months was maintained, but the extent of ablation (radiofrequency ablation time) was halved. 46 These new techniques of direct AF mapping improve the specificity and ability to detect AF drivers, facilitating termination of the arrhythmia while minimizing the extent of ablation.
Conclusions
The vast majority of studies demonstrate that procedural AF termination confers improved long-term freedom from atrial arrhythmias. Termination of the arrhythmia provides a robust measurable procedural end point, and bolstered by newer AF mapping techniques, facilitates a patient-tailored approach to persistent AF ablation. There exists a fundamental difference between a marker for a specific outcome and a widely achievable or even advisable strategic target. lim et al have provided evidence supporting the claim that conversion to sinus rhythm when achieved through catheter ablation of persistent atrial fibrillation (AF) is a favorable prognostic indicator of an improvement in longterm sinus rhythm maintenance. However, there is limited evidence to support a prospective strategy of continuing ablation in all patients with persistent AF toward a predetermined and often untenable goal of conversion to sinus rhythm. Furthermore, there is little mechanistic explanation to substantiate such a claim. Although it is often speculated that targeting sources or drivers during ablation should result in acute termination, this does not necessarily address recurrences because of later clinical presentation of additional drivers not identified or elicited at the time of ablation or whether identification and elimination of all potential drivers/perpetuators of AF during the ablation is achievable or even necessary. The pathophysiologic heterogeneity of persistent AF has led to variable outcomes among patients undergoing a rhythm control strategy. Even among those selected as ideal ablation candidates, some are likely to stay in sinus rhythm, whereas others are destined to have recurrent atrial arrhythmias despite extensive and often numerous attempts at substrate modification. What separates these groups is still poorly understood. Achieving sinus rhythm through ablation in all likelihood identifies patients with a more favorable atrial substrate and a greater chance of long-term sinus rhythm maintenance. Outcomes of catheter ablation, particularly for persistent AF often vary among centers. Such a disparity can be attributed to varying procedural strategies, postprocedure monitoring protocols, operator experience, attempts at repeat ablation, concomitant antiarrhythmic use, and patient selection. This variability limits our ability to compare or pool outcomes among multiple retrospective studies. large-scale prospective randomized trials will be helpful to definitively establish superiority of strategic approaches. However, there have been few such trials conducted to date and have shown inconsistent findings, with more recent trials suggesting less ablation. Although lim et al have provided a nice overview of prior outcomes from studies that used multiple ablation strategies, the justification for a prospective strategy of ablation until conversion still remains unanswered. Until our technology and understanding of mechanisms of AF and ability to precisely identify and eliminate them further advance, while our confidence may be understandably lifted by a patient's conversion to sinus rhythm during ablation of persistent AF, lengthy procedures in uncompromising pursuit of this goal seem to be unwarranted. This is not to say that we should accept the current status of ablation outcomes with persistent or even paroxysmal AF. In fact, current limitations of mapping and ablation technology should only strengthen our resolve and advance our efforts to better understand the mechanisms of AF, and translate this knowledge to improve our therapeutic efforts, including interventions on upstream pathogenetic pathways.
